- Home
- NUVB
NUVB
Nuvation Bio Inc.
as 11-20-2024 4:00pm EST
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 850.3M | IPO Year: | N/A |
| Target Price: | $6.17 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.22 - $4.16 | Next Earning Date: | 11-06-2024 |
| Revenue: | $2,162,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | -13.26% |
Latest Nuvation Bio Inc. News
NUVB Breaking Stock News: Dive into NUVB Ticker-Specific Updates for Smart Investing
Business Wire
9 days ago
Nuvation Bio to Present at the Jefferies London Healthcare Conference
Business Wire
15 days ago
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Insider Monkey
15 days ago
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline
Insider Monkey
a month ago
Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds?
Simply Wall St.
a month ago
Robert Mashal At Nuvation Bio Tops Up Holding By US$220k
Insider Monkey
a month ago
Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock?
Insider Monkey
a month ago
Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35
MT Newswires
a month ago
Nuvation Bio Names Philippe Sauvage CFO
Compare NUVB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NUVB Nuvation Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.